PureTech Health plc
PureTech Health plc (PRTC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRTC · as of Jun 9, 2026
Key Statistics
Explore PureTech Health plc Data
prtc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The PRTC analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $57.00, representing +227.21% upside from the current price of $17.42.
Competitors & Peers
prtc competitorsPRTC
ADCT
ALMS
AUTL
BNTC
LCTXStock Performance
Full HistoryAbout PureTech Health plc
PureTech Health plc operates as a clinical-stage biotherapeutics company, dedicated to the discovery, advancement, and market introduction of innovative medicines. The firm's therapeutic focus spans a…
what is puretech health plc · prtc stock overview · puretech health plc company profile · who is puretech health plc ceo · prtc NASDAQ · puretech health plc headquarters · puretech health plc business segments
About Stock Overview & Key Data
PureTech Health plc (PRTC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 16, 2020. As of the latest trading session, PRTC stock price is $17.42, with a market capitalization of $424.1M. The stock has returned -4.86% over the past 12 months and +4.69% year-to-date.
According to 2 Wall Street analysts, the consensus rating for PureTech Health plc stock is Buy, with an average 12-month price target of $57.00. In fiscal year 2025, PureTech Health plc reported revenue of $4.7M and net income of -$109.7M. For detailed data — including PureTech Health plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PureTech Health plc (PRTC) stock price is $17.42. The stock is traded on NASDAQ under the ticker symbol PRTC. The 52-week range is $14.50 – $19.92.